Q

Quanticate

Clinical data management and analysis services

Team Lead of Biometrics Automation & AI Architecture

Full-TimeUpdated on 10/23/2026
No salary listed
Senior, Expert
Bengaluru, Karnataka, India
HybridHybrid work in Bengaluru, India.
Biology & BiotechQuantitative Biology & Biostatistics

About the job

Requirements
  • Comprehensive understanding of clinical data standards, reporting practices, and regulatory frameworks.
  • Familiarity with artificial intelligence technologies, including large language models and retrieval-based systems.
  • Awareness of governance and validation requirements in regulated environments.
  • At least 8 years of relevant experience in biometrics or statistical programming within contract research organization, pharmaceutical, or healthcare research settings.
  • Practical experience with Clinical Data Interchange Standards Consortium implementation and clinical deliverables.
  • Proven involvement in automation or transformation initiatives.
  • Experience operating within global, cross-functional teams.
  • Strong programming capability in R, Python, and SAS.
  • Ability to design and manage scalable artificial intelligence-driven solutions.
  • Analytical thinking and problem-solving skills, especially with complex datasets.
  • Clear communication and stakeholder management abilities.
  • Leadership and team development skills.
  • High level of accuracy and focus on quality and compliance.
Responsibilities
  • Develop and lead the organization’s artificial intelligence strategy for statistical programming, including deployment of secure enterprise artificial intelligence platforms such as cloud-based large language model environments.
  • Build automated, metadata-driven pipelines that convert statistical analysis plans and shell specifications into production-ready code.
  • Establish governance frameworks for artificial intelligence use, including standard operating procedures, validation procedures, and audit controls aligned with Good Practice requirements.
  • Design safeguards within artificial intelligence-driven processes to appropriately handle missing or incomplete clinical data without introducing bias.
  • Ensure strict data protection standards so sensitive patient-level data and protected health information are never exposed to artificial intelligence systems.
  • Drive adoption of artificial intelligence tools by training and mentoring statistical programmers and data scientists in structured prompting and automated validation techniques.
  • Collaborate cross-functionally with biostatistics, quality assurance, and engineering teams to maintain regulatory compliance and technical excellence.

About the company

Quanticate is a global data-focused CRO that supports pharmaceutical, biotechnology, and medical device companies with the data side of clinical trials. It handles Clinical Data Management, Biostatistics, SAS Programming, data quality oversight via Centralized Statistical Monitoring, Medical Writing, and Pharmacovigilance, offering study-level support, functional service provision, strategic data-solutions, or technical consultancy. Its staff work on trial data to clean and organize it, perform analyses, write reports, and monitor quality, delivered through flexible models like dedicated teams, project-based work, or full data solutions. The goal is to be the supplier of choice for data-driven clinical research by delivering accurate, timely, and compliant data solutions that help speed and improve decision-making in trials.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Hitchin, United Kingdom

Founded

1994

Get referred to Quanticate

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quanticate updated its site in 2026, signaling active operations and continued talent investment.
  • The PhaseV service launched April 2024 targets adaptive trials, a higher-value niche for sponsors.
  • Cancer Research UK collaboration on DETERMINE links Quanticate to precision-oncology trial demand.

What critics are saying

  • Big pharma cuts at Novo Nordisk, Bayer, and Moderna squeeze CRO budgets through 2026.
  • Quanticate's 2024 partnerships are not proprietary products, so competitors can copy the model fast.
  • If sponsor demand weakens, this services-only CRO faces margin compression and hiring freezes by 2026.

What makes Quanticate unique

  • Quanticate pairs biostatistics, statistical programming, and clinical data management under one CRO.
  • The April 2024 PhaseV alliance adds adaptive-trial optimization software to its service stack.
  • Leadership pages show experienced operators, including Richard Morton and Sundar Ramamoorthy, across UK, US, India.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Flexible Work Hours
  • Paid Vacation
  • Paid Holidays
  • Paid Sick Leave
  • Health Insurance
  • Disability Insurance
  • Training Programs

Company News

Quanticate
Apr 25th, 2024
Quanticate announces strategic partnership with PhaseV

Quanticate announces strategic partnership with PhaseV.

World Pharma Today
Jun 2nd, 2023
Quanticate announces strategic partnership with KPS Life | World Pharma Today

Quanticate, a global biometric clinical research organization, is pleased to announce its strategic partnership with KPS Life, a US-based provider of Functional Service Provision solutions focused on clinical operations and clinical monitoring oversight.

Quanticate
Mar 7th, 2023
Quanticate is finalist at the Citeline Awards 2023

Quanticate is pleased to announce that Quanticate Inc. has been selected as a finalist for the Excellence in Use of Real-World Evidence category in the Citeline Awards 2023.

World Pharma Today
Jan 27th, 2023
Quanticate makes key appointment to bolster leadership team | World Pharma Today

Quanticate, a global data-focused clinical research organisation (CRO), has announced the appointment of Yolanda Barbachano as Head of Statistics.

PharmiWeb
Sep 27th, 2022
Quanticate Partners With Cancer Research Uk To Launch Determine Study

Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells. The first of its kind in the UK, the DETERMINE study will enrol patients with rare cancers, and aim to find out whether existing licensed drugs could be used to treat their type of cancer